Hitoshi Mochizuki
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 35
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 13
- SARS-CoV-2 detection and testing 11
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 16
-
- Lung Cancer Treatments and Mutations 20
- Pathology and Forensic Medicine top 10%
- Genetic factors in colorectal cancer 15
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 12
-
- BRCA gene mutations in cancer 8
- Co-authors
- Masao OmataYosuke HirotsuKenji AmemiyaToshio OyamaTaichiro GotoHiroshi NakagomiYumiko KakizakiYoshihiro Miyashita
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hitoshi Mochizuki
102 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Cancer Research 481
- Infectious Diseases 386
- Oncology 446
- Pulmonary and Respiratory Medicine 471
- Pathology and Forensic Medicine 201
Countries citing papers authored by Hitoshi Mochizuki
This map shows the geographic impact of Hitoshi Mochizuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Mochizuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Mochizuki more than expected).
Fields of papers citing papers by Hitoshi Mochizuki
This network shows the impact of papers produced by Hitoshi Mochizuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Mochizuki. The network helps show where Hitoshi Mochizuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitoshi Mochizuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 18 | |
| 6 | 2022 | 15 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 8 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 16 | |
| 14 | 2020 | 31 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 26 | |
| 17 | 2019 | 12 | |
| 18 | 2019 | 31 | |
| 19 | 2019 | 15 | |
| 20 | 2018 | 30 |
About Hitoshi Mochizuki
Hitoshi Mochizuki is a scholar working on Cancer Research, Oncology and Aging, having authored 109 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (35 papers), Lung Cancer Treatments and Mutations (20 papers), Pancreatic and Hepatic Oncology Research (16 papers), Genetic factors in colorectal cancer (15 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers), SARS-CoV-2 detection and testing (11 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Cancer Research (481 citations), Infectious Diseases (386 citations) and Oncology (446 citations). Hitoshi Mochizuki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Masao Omata, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Taichiro Goto, Hiroshi Nakagomi, Yumiko Kakizaki, Yoshihiro Miyashita, Toshiharu Tsutsui and Yuki Nagakubo. Their work appears in journals such as PLoS ONE, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.